Grace Therapeutics, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Grace Therapeutics, Inc. (GRCE) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $556.00 thousand for the 12-month period ending 2023-03-31, per its 10-K filed 2023-06-23.
Discontinued › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2024-02-12
- Grace Therapeutics, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $556.00K.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|
| 2023-03-31 | $556.00K 10-K · filed 2023-06-23 | |
| 2022-03-14 | $369.00K 10-Q · filed 2024-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |